1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.75%
Revenue growth above 1.5x 6203.T's 8.64%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
65.99%
Gross profit growth above 1.5x 6203.T's 15.95%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
52.93%
EBIT growth above 1.5x 6203.T's 16.67%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
59.53%
Operating income growth at 75-90% of 6203.T's 71.43%. Bill Ackman would demand a plan to enhance operating leverage.
39.28%
Net income growth above 1.5x 6203.T's 13.69%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
39.31%
EPS growth above 1.5x 6203.T's 13.71%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
39.31%
Diluted EPS growth above 1.5x 6203.T's 13.71%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Reduced diluted shares while 6203.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-95.18%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-56.35%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-48.31%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
97.04%
Net income/share CAGR above 1.5x 6203.T's 47.95% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-100.43%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1159.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
218.02%
5Y equity/share CAGR above 1.5x 6203.T's 37.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
12.04%
Positive short-term equity growth while 6203.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.17%
Our AR growth while 6203.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
30.87%
We show growth while 6203.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
18.56%
Positive asset growth while 6203.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.04%
We have a declining book value while 6203.T shows 0.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
63.62%
We have some new debt while 6203.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-41.99%
We cut SG&A while 6203.T invests at 1.33%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.